A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors
Clinical trial NCT02743637 · COMPLETED
Trial details
- NCT number
- NCT02743637
- Sponsor
- SynDevRx, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2019-12-16
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.